Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,147 | 68,880,813 | -0.65% | -0.54% | 1.56% | 10.55% | 8.13% | 14.96% |
| Healthcare | HEALTHCARE | Sector | 1,166 | 6,381,599 | 0.38% | 3.92% | 4.35% | 6.34% | -5.94% | -11.06% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 598 | 3,168,068 | 0.17% | 4.44% | 2.69% | 8.83% | -5.45% | -12.33% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 281 | 1,166,159 | 0.21% | 7.08% | -2.89% | 2.77% | -14.45% | -19.99% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 90 | 94,876 | -0.18% | 3.90% | 5.69% | 7.44% | -9.57% | -16.10% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 778 | -0.95% | 3.38% | -35.64% | 0.80% | -10.29% | 25.50% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 2,892 | -4.44% | -6.46% | -26.75% | -4.50% | -20.76% | 223.18% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 943 | -3.94% | -7.56% | -18.79% | 12.83% | -44.75% | -15.24% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 806 | -1.56% | -12.43% | -15.41% | 25.37% | 8.26% | 55.01% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 712 | -3.69% | -7.49% | -5.63% | 23.55% | 13.41% | 47.64% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 2,478 | 0.10% | -0.44% | -3.62% | -17.95% | -10.12% | 1.91% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 520 | -2.40% | -8.37% | -1.04% | 39.33% | 4.17% | -31.57% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 13,148 | -0.25% | 3.04% | 0.74% | 8.01% | 16.23% | -8.41% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 5,544 | 0.14% | 5.76% | 1.47% | 2.71% | -12.34% | 29.15% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,122 | 91,621,090 | -0.54% | -0.45% | 1.76% | 8.24% | 5.01% | 16.86% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,454 | -1.43% | 3.06% | 3.06% | -7.20% | -48.26% | -25.20% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 2,094 | -0.03% | 2.62% | 3.26% | 2.19% | 3.06% | 4.18% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 3,936 | -0.42% | 9.54% | 3.61% | 5.06% | -1.66% | 48.38% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 90 | 94,876 | -0.18% | 3.90% | 5.69% | 7.44% | -9.57% | -16.10% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 7,228 | 1.30% | 5.18% | 5.81% | 7.37% | -11.68% | 7.43% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,157 | -0.10% | 11.99% | 7.05% | 3.60% | -33.40% | -35.69% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 4,762 | 2.61% | 5.18% | 8.21% | -8.90% | -19.50% | 5.87% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 730 | 8.30% | 14.07% | 9.45% | 18.79% | -2.74% | -21.04% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,613 | -4.75% | 13.21% | 10.43% | -6.15% | -61.14% | -60.47% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 4,210 | -0.36% | -1.89% | 12.07% | 15.12% | 26.94% | 62.14% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 775 | -3.07% | -2.41% | 12.25% | -3.07% | 73.17% | 26.22% |
| ATAI Life Sciences NV | ATAI:USAATAI:USA | Stock | 1 | 843 | -1.98% | -3.87% | 12.46% | 93.66% | 89.95% | 225.41% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 20,357 | 2.17% | 7.70% | 13.19% | 6.37% | 1.59% | -31.23% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 2,874 | -1.22% | 3.81% | 18.64% | 18.87% | -2.96% | -1.45% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,357 | -2.30% | 1.84% | 26.39% | 26.51% | 25.30% | 21.56% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 1,401 | -0.65% | 5.42% | 33.59% | -0.73% | -11.36% | -73.01% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 1,012 | -0.11% | 36.66% | 50.20% | 83.98% | 98.82% | 26.38% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 1,972 | -3.86% | 7.34% | 51.50% | -49.54% | -81.16% | -84.88% |
* Colors indicate performance relative to the benchmark.